(4,4-Difluorocyclohex-1-en-1-yl)boronic acid, 98%, 1g

Scintillation vials, 4 ml, 2000 Piece(s)

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 250mg

1-[2-(isopropylamino)-4-methyl-1,3-thiazol-5-yl]ethanone, 100mg

2,5-Dimethylphenylacetonitrile, 98.0%, 2.5g

Methyl 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate, 95.0%, 10g

2-(3-Chloro-4-fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

4-Amino-6-chloro-pyrimidine-5-carbaldehyde, 95.0%, 2.5g

6-Hydroxy-5-nitronicotinic Acid>97.0%(GC)(T)5g

4-HYDROXY-8-METHOXY-2H-CHROMEN-2-ONE, 95%, 1g

2,2,2-Trichloro-1-(4-nitro-1h-pyrrol-2-yl)ethan-1-one, 95+%, 250mg

2-(Bromomethyl)pyrazine hydrobromide, 95.0%, 5g

Potassium hexadecyl hydrogenphosphate, 95.0%, 5g